SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer
Sheng He Bio -B (02898) announced that Ms. Jiang Xiaoling, an executive director, has been appointed as the Chief Executive Officer and Chief Science Officer of the company, effective from January 23, 2026.
SUNHO BIO-B (02898) announced that Ms. Jiang Xiaoling, an executive director, has been appointed as the Chief Executive Officer and Chief Scientific Officer of the company, effective from January 23, 2026.
Related Articles
GENSCRIPT BIO (01548): Meng Jiangge appointed as a director of Legend Biotech
CHINA SANDI (00910) issues a profit warning, expecting a loss of 4.403 billion yuan in 2024.
BANKOFJIUJIANG(06190): The Jiujiang City Finance Bureau intends to subscribe for no more than 500 million yuan of domestic shares.
GENSCRIPT BIO (01548): Meng Jiangge appointed as a director of Legend Biotech
CHINA SANDI (00910) issues a profit warning, expecting a loss of 4.403 billion yuan in 2024.
BANKOFJIUJIANG(06190): The Jiujiang City Finance Bureau intends to subscribe for no more than 500 million yuan of domestic shares.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
